Proathlete Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Proathlete Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.6K	Hold	930	–	–	0.01%	117
2026 Q1	$56.4K	Hold	930	–	–	0.02%	111
2025 Q4	$50.2K	Sell	930 -1,506	-62%	-$72.4K	0.01%	122
2025 Q3	$110K	Hold	2,436	–	–	0.03%	91
2025 Q2	$113K	Hold	2,436	–	–	0.04%	89
2025 Q1	$149K	Buy	+2,436	New	+$142K	0.05%	69

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Proathlete Wealth Management's BMY Position: Q2 2026 in Review

Proathlete Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 930 shares worth $53.6K. The position accounts for 0.01% of the portfolio, ranked #117.

Proathlete Wealth Management first reported a position in BMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $149K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Proathlete Wealth Management held 930 shares of Bristol-Myers Squibb worth $53.6K as of Q2 2026.
Proathlete Wealth Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.01% of Proathlete Wealth Management's portfolio in Q2 2026, its #117 holding.
Proathlete Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 6 quarters since.
Proathlete Wealth Management's Bristol-Myers Squibb position peaked at $149K in Q1 2025.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Proathlete Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.